4//SEC Filing
Bhat Laxminarayan 4
Accession 0001437749-23-011381
CIK 0001742927other
Filed
Apr 26, 8:00 PM ET
Accepted
Apr 27, 4:31 PM ET
Size
8.7 KB
Accession
0001437749-23-011381
Insider Transaction Report
Form 4
Bhat Laxminarayan
DirectorPresident and CEO10% Owner
Transactions
- Award
Stock Option (right to buy)
2023-04-25+443,000→ 443,000 totalExercise: $6.74Exp: 2033-04-24→ Common Stock, par value $0.0001 per share (443,000 underlying) - Award
Stock Option (right to buy)
2023-04-25+150,000→ 150,000 total(indirect: By Spouse)Exercise: $6.74Exp: 2033-04-24→ Common Stock, par value $0.0001 per share (150,000 underlying)
Footnotes (2)
- [F1]Represents an option award granted to Dr. Laxminarayan Bhat, the Issuer's President and Chief Executive Officer (the "Reporting Person"), by the Issuer's compensation committee on April 25, 2023 (the "Grant Date") in accordance with the terms of the Issuer's 2020 Equity Incentive Plan (the "2020 Plan"). The option vested as to fifty percent (50%) of the shares subject thereto on the Grant Date, and will vest as to an additional 1.389% of the shares subject thereto on the last day of each month thereafter. The exercise price is based on the closing price of the Issuer's common stock on the Grant Date in accordance with the terms of the 2020 Plan.
- [F2]Represents an option award granted to Ms. Seema Bhat, the Issuer's Vice President for Program & Portfolio Management and the spouse of the Reporting Person, by the Issuer's compensation committee on April 25, 2023 (the "Grant Date") in accordance with the terms of the 2020 Plan. The option vested as to fifty percent (50%) of the shares subject thereto on the Grant Date, and will vest as to an additional 1.389% of the shares subject thereto on the last day of each month thereafter. The exercise price is based on the closing price of the Issuer's common stock on the Grant Date in accordance with the terms of the 2020 Plan.
Documents
Issuer
REVIVA PHARMACEUTICALS HOLDINGS, INC.
CIK 0001742927
Entity typeother
Related Parties
1- filerCIK 0001818245
Filing Metadata
- Form type
- 4
- Filed
- Apr 26, 8:00 PM ET
- Accepted
- Apr 27, 4:31 PM ET
- Size
- 8.7 KB